The effect of growth hormone replacement therapy on cortisol-cortisone interconversion in hypopituitary adults: Evidence for growth hormone modulation of extrarenal 11β-hydroxysteroid dehydrogenase activity

Clinical Endocrinology

Volumn 48, Issue 2, 1998, Pages 153-162

  Gelding, S V ^a   Taylor, N F ^b   Wood, P J ^c   Noonan, K ^a   Weaver, J U ^e   Wood, D F ^a   Monson, J P ^d  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^d ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^e QUEEN ELIZABETH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; CORTISONE; GROWTH HORMONE; HYDROCORTISONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CORTICOTROPIN DEFICIENCY; DISEASE ASSOCIATION; DRUG EFFECT; ENZYME ACTIVITY; ENZYME REGULATION; FEMALE; GROWTH HORMONE DEFICIENCY; HORMONAL REGULATION; HORMONE METABOLISM; HORMONE SUBSTITUTION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; HYPOPITUITARISM; MALE; PRIORITY JOURNAL;

EID: 0031890042     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1998.3641180.x     Document Type: Article

References (36)

1. Albiston, A.L., Smith, R.E. & Krozowski, Z.S. (1995) Sex- and tissue-specific regulation of 11 beta-hydroxysteroid dehydrogenase. Molecular and Cellular Endocrinology, 109, 183-188.
2. Beshyah, S.A., Freemantle, C., Shahi, M., Anyaoku, V., Merson, S., Lynch, S., Skinner, E., Sharp, P., Foale, R. & Johnston, D.G. (1995a) Replacement treatment with biosynthetic human growth hormone in growth hormone-deficient hypopituitary adults. Clinical Endocrinology, 42, 73-84.
3. Beshyah, S.A., Gelding, S.V., Andres, C., Johnston, D.G. & Gray, I.P. (1995b) β-Cell function in hypopituitary adults before and during growth hormone treatment. Clinical Science, 89, 321-328.
4. Beshyah, S.A., Henderson, A., Niththyananthan, R., Skinner, E., Anyaoku, V., Richmond, W., Sharp, P. & Johnston, D.G. (1995c) The effects of short and long term growth hormone replacement therapy in hypopituitary adults on lipid metabolism and carbohydrate tolerance. Journal of Clinical Endocrinology and Metabolism. 80, 356-363.
5. Bevan, B.R., Savvas, M., Jenkins, J.M., Baker, K., Pennington, G.W. & Taylor, N.F. (1986) Abnormal steroid excretion in gestational trophoblastic disease complicated by ovarian theca-lutein cysts. Journal of Clinical Pathology, 39, 627-634.
6. Cuneo, R.C., Salomon, F., McGauley, G.A. & Sönksen, P.H. (1992) The growth hormone deficiency syndrome in adults. Clinical Endocrinology, 37, 387-397.
7. Hammami, H. & Siiteri, P.K. (1991) Regulation of 11β-hydroxysteroid dehydrogenase activity in human skin fibroblasts: enzymatic modulation of glucocorticoid action. Journal of Clinical Endocrinology and Metabolism, 73, 326-334.
8. Hellman, L., Bradlow, H.L., Zumoff, B. & Gallagher, T.F. (1961) The influence of thyroid hormone on hydrocortisone production and metabolism. Journal of Clinical Endocrinology and Metabolism, 21, 1231-1247.
9. Jamieson, P.M., Chapman, K.E., Edwards, C.R.W. & Seckl, J.R. (1995) 11β-Hydroxysteroid dehydrogenase type 1 (11β-OHSD-1) functions as a reductase in intact primary rat hepatocytes in culture. Journal of Endocrinology, 144, (suppl.): P164 (abstract).
10. Jørgensen, J.O.L., Pedersen, S.A., Laurberg, P., Weeke, J., Skakkebæk, N.E. & Christiansen, J.S. (1989a) Effects of growth hormone therapy on thyroid function of growth hormone-deficient adults with and without concomitant thyroxine-substituted central hypopituitarism. Journal of Clinical Endocrinology and Metabolism, 69, 1127-1132.
11. Jørgensen, J.O.L., Pedersen, S.A., Thuesen, L., Jørgenesen, J., Ingemann-Hansen, T., Skakkebaek, N.E. & Christiansen, J.S. (1989b) Beneficial effects of growth hormone treatment in GH-deficient adults. Lancet, i, 1221-1224.
12. Jørgensen, J.O., Moller, J., Laursen, T., Orskov, H., Christiansen, J.S. & Weeke, J. (1994) Growth hormone administration stimulates energy expenditure and extrathyroidal conversion of thyroxine to triiodothyronine in a dose-dependent manner and suppresses circadian thyrotrophin levels: studies in GH-deficient adults. Clinical Endocrinology, 41, 609-614.
13. Kahn, S.E., Horher, F.F., Prigeon, R.L., Haymond, M.W. & Porter, D. Jr, (1993) Effect of glucocorticoid and growth hormone treatment on proinsulin levels in humans. Diabetes, 42, 1082-1085.
14. Liu, Y-J., Nakagawa, Y., Nasuda, K., Saegusa, H. & Igarashi, Y. (1996) Effect of growth hormone, insulin and dexamethasone on 11β-hydroxysteroid dehydrogenase activity on a primary culture of rat hepatocytes. Life Sciences, 59, 227-234.
15. Low, S.C., Chapman, K.E., Edwards, C.R.W., Wells, T., Robinson, I.C.A.F. & Seckl, J.R. (1994) Sexual dimorphism of hepatic 11β-hydroxysteroid dehydrogenase in the rat: the role of growth hormone patterns. Journal of Endocrinology, 143, 541-548.
16. Markussis, V., Beshyah, S.A., Fisher, C., Sharp, P., Nicolaides, A.N. & Johnston, D.G. (1992) Detection of premature atherosclerosis by high-resolution ultrasonography in symptom-free hypopituitary adults. Lancet, 340, 1188-1192.
17. Monson, J.P., Weaver, J.U., Noonan, K. & Burrin, J.M. (1994) The effect of growth hormone on serum thyroid hormone concentrations and desmopressin requirements in adults with hypopituitarism and central diabetes insipidus. Endocrinology and Metabolism. 1 (Suppl. A), 51-55.
18. Moore, A., Aitken, R., Burke, C., Gaskell, S., Groom, G., Holder, G., Selby, C. & Wood, P. (1985) Cortisol assays: guidelines for the provision of a clinical biochemistry service. Annals of Clinical Biochemistry, 22, 435-454.
19. Palermo, M., Shackleton, C., Mantero, F. & Stewart, P. (1996) Urinary free cortisone and the assessment of 11β-hydroxysteroid dehydrogenase activity in man. Clinical Endocrinology, 45, 605-611.
20. Raven, P.W., Checkley, S.A. & Taylor, N.F. (1995) Extra-adrenal effects of metyrapone include inhibition of the 11-oxoreductase activity of 11β-hydroxysteroid dehydrogenase: a model for 11-HSD 1 deficiency. Clinical Endocrinology. 43, 637-644.
21. Raven, P.W. & Taylor, N.F. (1995) Steroid metabolism in healthy men and women. Journal of Endocrinology, 147 (Suppl.), P100 (abstract).
22. Rodriguez-Amao, J., Perry, L., Besser, G.M. & Ross, R.J.M. (1996) Growth hormone treatment in hypopituitary adults reduces circulating cortisol levels during hydrocortisone replacement therapy. Clinical Endocrinology, 45, 33-37.
23. Rosén, T. & Bengtsson, B-Å. (1990) Premature mortality due to cardiovascular disease in hypopituitarism. Lancet, 336, 285-288.
24. Russell-Jones, D.L., Watts, G.F., Weissberger, A., Naoumova, R., Myers, J., Thompson, G.R. & Sönksen, P.H. (1994) The effect of growth hormone replacement on serum lipids, lipoproteins, apolipoproteins and cholesterol precursors in adult growth hormone deficient patients. Clinical Endocrinology, 41, 345-350.
25. Salomon, F., Cuneo, R.C., Hesp, R. & Sönksen, P.M. (1989) The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. New England Journal of Medicine, 321, 1797-1803.
26. Seckl, J.R. (1993) 11β-Hydroxysteroid dehydrogenase isoforms and their implications for blood pressure regulation. European Journal of Clinical Investigation, 23, 589-601.
27. Seckl, J.R. (1995) The syndrome of apparent mineralocorticoid excess and deficiency of 11β-hydroxysteroid dehydrogenase. Clinical Endocrinology. 43, 247-248.
28. Stewart, P.M. (1996) 11β-Hydroxysteroid dehydrogenase: implications for clinical medicine. Clinical Endocrinology, 44, 493-199.
29. Tannin, G.M., Agarwal, A.K., Monder, C., New, M.I. & White, P.C. (1991) The human gene for 11β-hydroxysteroid dehydrogenase. Journal of Biological Chemistry, 266, 16653-16658.
30. Walker, B.R. & Edwards, C.R.W. (1991) 11β-Hydroxysteroid dehydrogenase and enzyme-mediated receptor protection: life after liquorice? Clinical Endocrinology, 35, 281-289.
31. Walker, B.R., Connacher, A.A., Lindsay, R.M., Webb, D.J. & Edwards, C.R.W. (1995) Carbenoxolone increases hepatic insulin sensitivity in man: a novel role for 11-oxosteroid reductase in enhancing glucocorticoid receptor activation. Journal of Clinical Endocrinology and Metabolism, 80, 3155-3159.
32. Weaver, J.U., Thaventhiran, L., Noonan, K., Burrin, J.M., Taylor, N.F., Norman, M.R. & Monson, J.P. (1994) The effect of growth hormone replacement on cortisol metabolism and glucocorticoid sensitivity in hypopituitary adults. Clinical Endocrinology, 41, 639-648.
33. Weaver, J.U., Monson, J.P., Noonan, K., John, W.G., Edwards. A., Evans, K.A. & Cunningham, J. (1995) The effect of low dose recombinant human growth hormone replacement on regional fat distribution. insulin sensitivity, and cardiovascular risk factors in hypopituitary adults. Journal of Clinical Endocrinology and Metabolism, 80, 153-159.
34. Weaver, J.U., Kelly, W.F., Bilous, R.W., Monson, J.P. & Taylor, N.F. (1996) Sexual dimorphism in 11β hydroxysteroid dehydrogenase activity in hypopituitarism; effect of body fat distribution. Journal of Endocrinology, 148 (Suppl.): P43 (abstract).
35. Whitehead, H.M., Boreham, C., McIlrath, E.M., Sheridan, B., Kennedy, L., Atkinson, A.B. & Hadden, D.R. (1992) Growth hormone treatment of adults with growth hormone deficiency: results of a 13-month placebo controlled cross-over study. Clinical Endocrinology, 36, 45-52.
36. Zumoff, B., Bradlow, H.L., Levin, J. & Fukushima, D.K. (1983) Influence of thyroid function on the in vivo cortisol-cortisone equilibrium in man. Journal of Steroid Biochemistry, 18, 437-440.